| |
|
|
|
HTG Molecular Diagnostics Inc.  
|
|
2.51 0.16 (0.07%) |
02-19 16:00 |
|
Open: |
2.38 |
Pre close: |
2.35 |
Target:
|
3.03 
|
|
High: |
2.55 |
Low: |
2.32 |
Resistance:
|
2.59
3.03
|
|
Volume: |
373,139 |
Market Cap: |
72M |
Support:
|
2.24
2.03
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.35
 |
MACD |
MACD(12,26):
|
-0.04 |
|
MA(20): |
2.22 |
Signal(12,26,9): |
-0.09 |
|
MA(100): |
3.14 |
Stochastic Oscillator |
%K(14,3):
|
79.83 |
|
MA(250): |
3.54 |
%D(3): |
73.75 |
|
Average Volume(K) |
3-Month: |
30770
|
52-Week |
High:
|
5.83 |
|
10-Days: |
32661 |
Low: |
2.03 |
|
RSI |
RSI(14):
|
61.26 |
Change(%): |
-51.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.680 |
Return on Equity (ttm) |
-177.4 |
Shares Out. (M) |
28.50 |
|
EPS Est. Current Year |
-2.290 |
Return on Assets (ttm) |
-52.4 |
Shares Float (M) |
27.78 |
|
EPS Est. Next Year |
-1.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.480 |
Qtrly Rev. Growth |
26.4 |
% Held by Institutions |
83.60 |
|
Forward EPS |
-0.720 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
2.880 |
EBITDA (p.s.) |
0.000 |
P/E |
-3.69 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.87 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.42 |
P/S |
77755432.00 |
|
Operating Margin |
-72.77 |
Levered Free Cash Flow
(M) |
-8.90 |
P/CF |
-5.33 |
|
|
|
|
|
|
